PHAXIAM Therapeutics S.A. (PHXM) — Cash Flow Reinvestment Rate

Latest as of December 2012: 0.08x

PHAXIAM Therapeutics S.A. (PHXM) has a Cash Flow Reinvestment Rate of 0.08x as of December 2012, reinvesting €48.40K (capex €48.40K ) from operating cash flow of €621.40K. Check PHXM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.08x

(Capex + Investments) / Operating CF

Total Reinvested

€48.40K

Capex + Investments

Operating Cash Flow

€621.40K

EUR

Capital Expenditures

€48.40K

EUR

PHAXIAM Therapeutics S.A. Cash Flow Reinvestment Rate (2012–2012)

Historical reinvestment intensity for PHAXIAM Therapeutics S.A. across 1 annual periods. Explore long-term investment intensity of PHAXIAM Therapeutics S.A. to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for PHAXIAM Therapeutics S.A. (2012–2012)

Year-by-year capital reinvestment analysis for PHAXIAM Therapeutics S.A.. For live market cap and broader valuation context, see PHAXIAM Therapeutics S.A. (PHXM) market capitalisation.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2012	0.08x	€52.50K	€621.40K	€52.50K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow